The 4 analysts offering 12-month price forecasts for Aveo Pharmaceuticals Inc have a median target of 23.00, with a high estimate of 27.00 and a low estimate of 18.00. The median estimate represents a +264.50% increase from the last price of 6.31.
The current consensus among 4 polled investment analysts is to Buy stock in Aveo Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.55
Reporting Date May 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.